Innovation in gynaecological brachytherapy: new technologies, pulse dose-rate brachytherapy, image, definition of new volumes of interest and their impact on dosimetry: application in a clinical research programme "STIC";Nouveautés en curiethérapie gynécologique : nouvelles technologies, curiethérapie pulsée, imagerie, définitions de nouveaux volumes d'intérêt et leur impact sur la dosimétrie : applications dans le cadre d'un STIC

Cancer/Radiotherapie

Volumn 10, Issue 6-7, 2006, Pages 402-409

  Haie Meder, C ^a   Peiffert, D ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

Author keywords

Brachytherapy; Cervix cancer; Optimization; PDR; Three dimensional dosimetry

Indexed keywords

BRACHYTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; GYNECOLOGICAL EXAMINATION; HUMAN; INCIDENCE; INFORMATION PROCESSING; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE RISK; SHORT SURVEY; UTERINE CERVIX CANCER; UTERUS PERFORATION; X RAY; ARTICLE; FEMALE; FEMALE GENITAL SYSTEM; FEMALE GENITAL TRACT TUMOR; HISTOLOGY; IMAGE ENHANCEMENT;

BRACHYTHERAPY; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITALIA, FEMALE; HUMANS; IMAGE ENHANCEMENT; RADIOTHERAPY DOSAGE;

EID: 33750453064     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.06.007     Document Type: Short Survey

References (28)

1. Briot E., de Crevoisier R., Petrow P., and Haie-Meder C. Dose-volume histogram analysis for tumour and critical organs in intracavitary brachytherapy of cervical cancer with the use of MRI. Radiother. Oncol. 60 (2001) S3
2. Burghardt E., Hofman H.M., Ebner F., Haas J., Tamussino K., and Justich E. Magnetic resonance imaging in cervical cancer: a basis for objective classification. Gynecol. Oncol. 33 (1989) 61-67
3. Cetingoz R., Ataman O., Tuncel N., Sen M., and Kinay M. Optimisation in high dose-rate brachytherapy for uterovaginal applications. Radiother. Oncol. 58 (2001) 31-36
4. Charra-Brunaud C., Ahmad F., Métayer Y., Haie-Meder C., Thomas L., Barillot I., et al. Délinéation des volumes en curiethérapie gynécologique et implications dosimétriques. Expérience du groupe STIC 2004 curiethérapie de débit pulsé en gynécologie et dosimétrie tridimensionnelle. Société française de radiothérapie oncologique. Paris. F. Cancer Radiother. 9 (2005) 547
5. Dimopoulos J.C., Schard G., Berger D., Lang S., Goldner G., Helbich T., et al. Systematic evaluation of IMN findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int. J. Radiat. Oncol. Biol. Phys. 64 (2006) 1380-1388
6. Erickson B. The sculpted pear: an unfinished brachytherapy tale. Brachytherapy 2 (2003) 189-199
7. Gong Q.Y., Tan L.T., Romaniuk C.S., Brunt J.N., and Roberts N. Determination of tumour regression rates during radiotherapy for cervical carcinoma by serial MRI: comparison of two measurement techniques and examination of intraobserver and interobserver variability. Br. J. Radiol. 72 (1999) 62-72
8. Haie-Meder C., de Crevoisier R., Petrow P., et al. Curiethérapie dans les cancers du col utérin : évolution des techniques et des concepts. Cancer Radiother. 7 (2003) 42-47
9. Haie-Meder C., Lhommé C., de Crevoisier R., Morice P., and Resbeut M. Radiochimiothérapie concomitante dans les cancers du col utérin : modifications des standards. Cancer Radiother. 4 (2000) 134-140
10. Haie-Meder C., Pötter R., Van Limbergen E., Briot E., De Brabandere M., Dimopoulos J., et al. Recommendations from gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother. Oncol. 74 (2005) 235-245
11. Hellebust T.P., Dale E., Skjonsberg A., and Olsen D.R. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose-rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother. Oncol. 60 (2001) 273-280
12. ICRU, International Commission of Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynaecology. ICRU Report 38, Bethesda, MD; 1985.
13. Kim S.H., Choi B.I., and Han J.K. Preoperative staging of uterine cervical carcinoma: comparison of CT and MR in 99 patients. J. Comput. Assist. Tomogr. 17 (1993) 633-640
14. Kirisits C., Pötter R., Lang S., Dimopoulos J., Wachter-Gerstner N., and Georg D. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 901-911
15. Lang S., Nulens A., Briot E., Kirisits C., De Brabandere M., Dumas I., et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother. Oncol. 78 (2006) 185-193
16. Mayr N.A., Taoka T., Yuh W., et al. Method and timing of tumour volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 52 (2002) 14-22
17. Mayr N.A., Yuh W.T.C., Zheng J., Ehrhardt J.C., Sorosky J., Magnotta V.A., et al. Tumour size evaluated by pelvic examination compared with 3-D MR quantitative analysis in the prediction of outcome for cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 39 (1997) 395-404
18. Muschitz S., Petrow P., Briot E., Petit C., de Crevoisier R., Duvillard P., et al. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma. Radiother. Oncol. 73 (2004) 187-194
19. Orton C.G., Brenner D.J., Dale D.G., and Fowler J.F. Radiobiology. In: Nag S. (Ed). High dose-rate brachytherapy: a textbook (1994), Futura Publishing Company, New York
20. Peiffert D., Carolus J.M., Guillemin F., Verhaeghe J.L., et al. Statistical study of a series of 672 cases of carcinoma of the uterine cervix, Results and complications according to age and modalities of treatment. Bull. Cancer 8 (1995) 568-581
21. Pötter R., Haie-Meder C., Van Limbergen E., Barillot I., De Brabandere M., Dimopoulos J., et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (II): concepts and terms in 3D image-based 3D treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother. Oncol. 78 (2006) 66-77
22. Pötter R., Knocke T.H., Fellner C., Baldass M., Reinthaller A., and Kucera H. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother. 4 (2000) 159-172
23. Pötter R., Van Limbergen E., Gerstner N., and Wambersie A. Survey of the use of ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother. Oncol. 58 (2001) 11-18
24. Stitt J.A., Fowler J.F., Thomadsen B.R., et al. High dose-rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Int. J. Radiat. Oncol. Biol. Phys. 1 (1992) 313-317
25. Subak L.L., Hricak H., Powell C.B., Azizi L., and Stern J.L. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging (Review). Obstet. Gynecol. 86 (1995) 43-50
26. Tardivon A., Kinkel K., Lartigau E., Masselot J., Gerbaulet A., and Vanel D. MR imaging during intracavitary brachytherapy of vaginal and cervical cancers: preliminary results. Radiographics 16 (1996) 1363-1370
27. Wachter-Gerstner N., Wachter S., Reinstadler E., et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother. Oncol. 68 (2003) 269-276
28. Wachter-Gerstner N., Wachter S., Reinstadler E., Fellner C., Knocke T.H., and Pötter R. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of prospective comparative trial. Radiother. Oncol. 68 (2003) 51-59